[Incidence and type of dyslipidemia in a diabetic population].

Clin Ter

II Divisione Medica e Sez. Aggr. Diabetologia, e Malattie Metaboliche, U.S.L. 13, area livornese.

Published: March 1994

The incidence of dyslipidemia in the diabetic patients tested was found to be twofold compared to the non diabetic population. The percentage was found to be higher in Fredrikson class IIb, unchanged in class IIa and diminished in class IVF.

Download full-text PDF

Source

Publication Analysis

Top Keywords

dyslipidemia diabetic
8
[incidence type
4
type dyslipidemia
4
diabetic population]
4
population] incidence
4
incidence dyslipidemia
4
diabetic patients
4
patients tested
4
tested twofold
4
twofold compared
4

Similar Publications

Objective: HAPpEN aims to implement and evaluate a holistic general practitioner-centered, interdisciplinary obesity management strategy in rural Germany, focusing on feasibility, health outcomes, and economic benefits.

Methods: HAPpEN is a 12-month, pragmatic single-arm, multicenter trial, informed by a formative survey, and initiated in April 2023 with 98 obese participants (body mass index, BMI ≥ 30 kg/m) in Kulmbach, Germany. The program integrates nutritional counseling, physical activity, and behavior change techniques, including smartphone-based self-monitoring.

View Article and Find Full Text PDF

Periodontal pathogens and obesity in the context of cardiovascular risks across age groups.

Front Oral Health

January 2025

Department of Cardiovascular Pathology and Diet Therapy, Federal Research Centre for Nutrition, Biotechnology and Food Safety, Moscow, Russia.

Background: Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity among noncommunicable diseases. Over the past decade, there has been a notable increase in the prevalence of CVDs among young individuals. Obesity, a well-known risk factor for CVDs, is also associated with various comorbidities that may contribute to cardiovascular risk.

View Article and Find Full Text PDF

Association of blood group types and clinico-pathological features of gynecological cancers (GCs).

BMC Cancer

January 2025

Molecular Diseases & Diagnostics Division, Infinity Biochemistry, Infinity Solutions Unlimited, Sajjad Abad, Chattabal, Srinagar, 190010, Kashmir, India.

Background: Gynecological cancers (GCs) affect the reproductive system of females, and are of multiple types depending on the affected organ most common of which are cervical, endometrial, ovarian cancers. Among different risk factors for GCs, ABO blood group system is considered as one of the pivotal contributing factors for increased susceptibility of GCs. The aim of our study was to report on the demographics of GC patients and to investigate the relationship between the ABO blood group system and the risk of acquiring GC in our population.

View Article and Find Full Text PDF

Metabolic dysfunction-associated steatotic liver disease in children.

Gut

January 2025

Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, is the most common cause of chronic liver disease in children. MASLD encompasses a spectrum of liver disease and can be severe, with 10% of affected children presenting with advanced fibrosis. While biopsy remains the most accurate method for diagnosing and staging the disease, MRI proton density fat fraction and magnetic resonance elastography are the most reliable non-invasive measures for assessing steatosis and fibrosis, respectively.

View Article and Find Full Text PDF

Skeletal muscle disorders as risk factors for type 2 diabetes.

Mol Cell Endocrinol

January 2025

Department of Physiology and Biophysics, Rush University, Chicago, United States.

The incidence and prevalence of muscular disorders and of type 2 diabetes (T2D) is increasing and both represent highly significant healthcare problems, both economically and compromising quality of life. Interestingly, skeletal muscle dysfunction and T2D share some commonalities including dysregulated glucose homeostasis, increased oxidative stress, dyslipidemia, and cytokine alterations. Several lines of evidence have hinted to a relationship between skeletal muscle dysfunction and T2D.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!